KRISTINA FAIR: Open Payments
NPI 1477984953 · RAHWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 55 payments from 17 companies in 2025. Trend: 2023 $1,305 · 2024 $1,288 · 2025 $1,141
Food & beverage: $1,056Education: $85
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $179 |
| Sumitomo Pharma America, Inc. | 6 | $109 |
| Dendreon Pharmaceuticals LLC | 5 | $87 |
| Endo USA, Inc. | 5 | $87 |
| SEAGEN INC. | 1 | $85 |
| 180 Medical, Inc. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| TOLMAR, INC. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $61 |
Products named: XTANDI, GEMTESA, LYNPARZA, PROVENGE, AVEED, Nubeqa, ERLEADA, JATENZO.
Industry payments across NJ — which companies pay providers there.
